详情页 - 首都医科大学宣武医院知识库

当前位置：首页 > 详情页

Report from the First Clinical Trials on Alzheimer's Disease (CTAD) Asia-China 2018: Bringing together Global Leaders

文献详情

资源类型：

WOS体系：

收录情况： ◇ SCIE

作者：

机构： [1]Department of Neurobiology, Geriatrics and Neurology, Xuanwu Hospital of Capital Medical University, Beijing, China [2]China National Clinical Research Center for Geriatric Disorders, Xuanwu Hospital of Capital Medical University, Beijing, China [3]Department of Geriatrics, Gerontopole, World Health Organization (WHO) Collaborating Center for Frailty, Clinical Research and Geriatric training, University of Toulouse, France [4]INSERM U 1061, University Hospital of Montpellier Montepellier, France [5]McGill Center for Studies in Aging, Montreal, Canada

出处：

DOI：

ISSN：

关键词： Dementia Alzheimer's disease China chinese clinical trials CTAD

摘要：

Population of older adults in Asia, and particularly in China is increasing rapidly. Older population are at increased risk of Alzheimer's disease (AD) and other dementias. Soon, the Chinese population with AD will represent almost half of the world's AD population. There is a desperate need of disease modifying therapies to delay or slow the progression of AD, to tackle this emerging healthcare emergency. In this context, the first CTAD Asia-China conference was held in China to bring together Western and Asian leaders in AD. This meeting focused largely on how to develop successful trials in China, utilizing past experiences from the West.

语种：

被引次数：

WOS：

PubmedID：

中科院(CAS)分区：

出版当年[2018]版：

无

最新[2023]版：

大类 | 3 区医学

小类 | 3 区临床神经病学

JCR分区：

出版当年[2017]版：

无

最新[2023]版：

Q1 CLINICAL NEUROLOGY

影响因子： 8.5 最新[2023版] 6.9 最新五年平均 0 出版当年[2017版] 0 出版当年五年平均 0 出版前一年[2016版]

第一作者：

第一作者机构： [1]Department of Neurobiology, Geriatrics and Neurology, Xuanwu Hospital of Capital Medical University, Beijing, China [2]China National Clinical Research Center for Geriatric Disorders, Xuanwu Hospital of Capital Medical University, Beijing, China [3]Department of Geriatrics, Gerontopole, World Health Organization (WHO) Collaborating Center for Frailty, Clinical Research and Geriatric training, University of Toulouse, France [*1]Department of Neurobiology, Geriatrics and Neurology, Xuanwu Hospital of Capital Medical University, Beijing, China

通讯作者：

通讯机构： [*1]Department of Neurobiology, Geriatrics and Neurology, Xuanwu Hospital of Capital Medical University, Beijing, China

推荐引用方式(GB/T 7714)：

APA：

MLA：

相关文献

[1]Prevalence of Alzheimer's disease and other dementing disorders in an urban community of Beijing, China [2]Cerebrolysin in Mild-to-Moderate Alzheimer's Disease: A Meta-Analysis of Randomized Controlled Clinical Trials [3]Fluid Biomarkers in Clinical Trials for Alzheimer's Disease: Current and Future Application. [4]A Bayesian perspective on Biogen's aducanumab trial [5]CSF cholinesterase in early‐onset and lateonset Alzheimer's disease and multi‐infarct dementia of Chinese patients [6]Attention Network Dysfunctions in Lewy Body Dementia and Alzheimer's Disease [7]The cost of Alzheimer's disease in China and re-estimation of costs worldwide [8]Associated Factors of Total Costs of Alzheimer's Disease: A Cluster-Randomized Observational Study in China. [9]The cost of Alzheimer's disease in China and re-estimation of costs worldwide [10]Perspectives on a collaborative Canada-China research program on diagnostic biomarkers for pre-dementia stages of Alzheimer's disease